These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6360756)

  • 1. Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double-blind cross-over study in type II diabetics.
    Prager R; Schernthaner G
    Diabetes; 1983 Dec; 32(12):1083-6. PubMed ID: 6360756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
    Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
    Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
    Prager R; Schernthaner G; Graf H
    Diabete Metab; 1986 Dec; 12(6):346-50. PubMed ID: 3817257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study.
    Kobayashi M; Shigeta Y; Hirata Y; Omori Y; Sakamoto N; Nambu S; Baba S
    Diabetes Care; 1988 Jun; 11(6):495-9. PubMed ID: 3042317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
    Wu MS; Johnston P; Sheu WH; Hollenbeck CB; Jeng CY; Goldfine ID; Chen YD; Reaven GM
    Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.
    Fantus IG; Brosseau R
    J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.
    Sidharta PN; Rave K; Heinemann L; Chiossi E; Krähenbühl S; Dingemanse J
    Br J Clin Pharmacol; 2009 Oct; 68(4):502-10. PubMed ID: 19843053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of metformin action in non-insulin-dependent diabetes.
    Jackson RA; Hawa MI; Jaspan JB; Sim BM; Disilvio L; Featherbe D; Kurtz AB
    Diabetes; 1987 May; 36(5):632-40. PubMed ID: 3552795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.
    Vardarli I; Arndt E; Deacon CF; Holst JJ; Nauck MA
    Diabetes; 2014 Feb; 63(2):663-74. PubMed ID: 24186866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.